Cardiac Wire #83 May 18, 2023
Vascepa’s Coronary Physiology Impact | Stress & CVD
Cardiac Wire #82 May 15, 2023
Philips’ Echo AI Acquisition | Metformin’s CV Potential
Cardiac Wire #81 May 11, 2023
Farxiga’s HF Extension | Statins’ Blood Vessel Benefits
Cardiac Wire #80 May 8, 2023
Tirzepatide Delivers Again | Climate Change Driving CVD
Cardiac Wire #79 May 4, 2023
Depression’s CVD Link | Heart Seat Monitoring
Cardiac Wire #78 May 1, 2023
A Case for BP Polypills | Interventional Bullies
Cardiac Wire #77 April 27, 2023
Telehealth-First Cardiology VBC | LDL-C Public Health Crisis
Cardiac Wire #76 April 24, 2023
CVD Screening Goes Retinal & Retail | CVD’s Cancer Risks
Cardiac Wire #75 April 20, 2023
Cardiology’s AI Opportunity | Ablation Delays Are OK
Cardiac Wire #74 April 17, 2023
Personalized Hypertension Medicine | Heart Research in Space
Cardiac Wire #73 April 13, 2023
Is Moderate Exercise Safe on Statins? | ABIM MOC Backlash
Cardiac Wire #72 April 10, 2023
HeartFlow’s Big Series F | Two Very Different Aktiia Studies
Cardiac Wire #71 April 6, 2023
Echo AI Improves LVEF | HF + AS Outcomes
Cardiac Wire #70 April 3, 2023
The Consequences of AF Ablation Delays | Jardiance’s Huge Year
Cardiac Wire #69 March 30, 2023
Procyrion Aortix’s CRS Impact | RV’s Week in the Spotlight
Cardiac Wire #68 March 27, 2023
Ancora Heart’s TLVR Milestone | Cardiology’s Mainstream Week
Cardiac Wire #67 March 23, 2023
The Big Impact of Small Cardiorespiratory Changes | vMap Ablation’s Improved Outcomes
Cardiac Wire #66 March 20, 2023
Esperion’s Milestone Faceoff | TEER Outcomes
Cardiac Wire #65 March 16, 2023
